1. Home
  2. COCO vs PBLS Comparison

COCO vs PBLS Comparison

Compare COCO & PBLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Vita Coco Company Inc.

COCO

The Vita Coco Company Inc.

N/A

Current Price

$67.44

Market Cap

4.2B

ML Signal

N/A

Logo Parabilis Medicines Inc. Common Stock

PBLS

Parabilis Medicines Inc. Common Stock

N/A

Current Price

$31.63

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
COCO
PBLS
Founded
2004
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
3.6B
IPO Year
2021
2026

Fundamental Metrics

Financial Performance
Metric
COCO
PBLS
Price
$67.44
$31.63
Analyst Decision
Buy
Analyst Count
9
0
Target Price
$57.75
N/A
AVG Volume (30 Days)
1.3M
463.8K
Earning Date
04-29-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
26.60
N/A
EPS
1.32
N/A
Revenue
N/A
N/A
Revenue This Year
$16.12
N/A
Revenue Next Year
$11.40
N/A
P/E Ratio
$49.98
N/A
Revenue Growth
N/A
N/A
52 Week Low
$31.82
$25.56
52 Week High
$85.83
$33.65

Technical Indicators

Market Signals
Indicator
COCO
PBLS
Relative Strength Index (RSI) 39.04 57.89
Support Level $65.11 $26.83
Resistance Level $69.59 $33.65
Average True Range (ATR) 3.91 2.51
MACD -0.53 0.16
Stochastic Oscillator 9.85 69.57

Price Performance

Historical Comparison
COCO
PBLS

About COCO The Vita Coco Company Inc.

The Vita Coco Co Inc is a plant-based functional hydration platform. Its products include Vita Coco Coconut Water, Private Label including coconut water and oil, and Other including Runa, Ever & Ever, and PWR LIFT product offerings, Vita Coco product extensions beyond coconut water, such as Vita Coco Sparkling, coconut milk products, and others. The company has two segments: The Americas segment which comprises of operations in the U.S. and Canada; and The International segment that comprises of operations in Europe, the Middle East, Africa and the Asia Pacific regions. The Americas segment derives maximum revenue. Geographical presence of the company is in United States, United Kingdom and All other countries.

About PBLS Parabilis Medicines Inc. Common Stock

Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.

Share on Social Networks: